Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
33 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
106.4 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
34
34 articles ont été cités au moins 34fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
5 366
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
96
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
56
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Centre Hospitalier de Valence · BIOASTER
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Apprivoiser l'incertitude et simuler des situations de crise par des jeux en grappe et des intelligences artificielles d’assistance aux décisions
2026Congrès3e Assises françaises d’étude du wargaming
DC subsets and states unraveled across human juxtatumoral and malignant tissues
2025ArticleNature Immunology
Pulse-Shape Analysis for Solar Energetic Particle Discrimination around Mars
2025ArticleIEEE Transactions on Nuclear Science
Partially Observable Monte-Carlo Graph Search
2025CongrèsInternational Conference on Automated Planning and Scheduling
How to Exhibit More Predictable Behaviors
2025ArticleThe European Journal on Artificial Intelligence
Observer-Aware Probabilistic Planning under Partial Observability
2025CongrèsAAMAS 2025 - 24th International Conference on Autonomous Agents and Multiagent Systems
First results from the DORN experiment onboard the Chang’E 6 mission
2025CongrèsEGU General Assembly 2025
Mycoplasma pneumoniae infection in adult inpatients during the 2023–24 outbreak in France (MYCADO): a national, retrospective, observational study
2025ArticleThe Lancet Infectious Diseases
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHU DE MARTINIQUE SITE P.ZOBDA QUITMAN
QUA LA MEYNARD CS 90632, 97261 FORT DE FRANCE CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
FEMS microbiology reviews · 2021
ABSTRACTCandida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial barriers and immune defences. Their perturbation can lead to fungal outgrowth and the development of mucosal infections such as oropharyngeal or vulvovaginal candidiasis, and patients with compromised immunity are susceptible to life-threatening systemic infections. The importance of the interplay between fungus, host and microbiota in driving the transition from C. albicans commensalism to pathogenicity is widely appreciated. However, the complexity of these interactions, and the significant impact of fungal, host and microbiota variability upon disease severity and outcome, are less well understood. Therefore, we summarise the features of the fungus that promote infection, and how genetic variation between clinical isolates influences pathogenicity. We discuss antifungal immunity, how this differs between mucosae, and how individual variation influences a person's susceptibility to infection. Also, we describe factors that influence the composition of gut, oral and vaginal microbiotas, and how these affect fungal colonisation and antifungal immunity. We argue that a detailed understanding of these variables, which underlie fungal-host-microbiota interactions, will present opportunities for directed antifungal therapies that benefit vulnerable patients.
International journal of environmental research and public health · 2022
(1) Background: Cardiopulmonary and brain functions are frequently impaired after COVID-19 infection. Exercise rehabilitation could have a major impact on the healing process of patients affected by long COVID-19. (2) Methods: The COVID-Rehab study will investigate the effectiveness of an eight-week cardiopulmonary rehabilitation program on cardiorespiratory fitness (V˙O2max) in long-COVID-19 individuals. Secondary objectives will include functional capacity, quality of life, perceived stress, sleep quality (questionnaires), respiratory capacity (spirometry test), coagulation, inflammatory and oxidative-stress profile (blood draw), cognition (neuropsychological tests), neurovascular coupling and pulsatility (fNIRS). The COVID-Rehab project was a randomised clinical trial with two intervention arms (1:1 ratio) that will be blindly evaluated. It will recruit a total of 40 individuals: (1) rehabilitation: centre-based exercise-training program (eight weeks, three times per week); (2) control: individuals will have to maintain their daily habits. (3) Conclusions: Currently, there are no specific rehabilitation guidelines for long-COVID-19 patients, but preliminary studies show encouraging results. Clinicaltrials.gov (NCT05035628).
Microbiome · 2022
AbstractBackgroundThere is a growing interest in using gut commensal bacteria as “next generation” probiotics. However, this approach is still hampered by the fact that there are few or no strains available for specific species that are difficult to cultivate. Our objective was to adapt flow cytometry and cell sorting to be able to detect, separate, isolate, and cultivate new strains of commensal species from fecal material. We focused on the extremely oxygen sensitive (EOS) speciesFaecalibacterium prausnitziiand the under-represented, health-associated keystone speciesChristensenella minutaas proof-of-concept.ResultsA BD Influx® cell sorter was equipped with a glovebox that covered the sorting area. This box was flushed with nitrogen to deplete oxygen in the enclosure. Anaerobic conditions were maintained during the whole process, resulting in only minor viability loss during sorting and culture of unstainedF. prausnitziistrains ATCC 27766, ATCC 27768, and DSM 17677. We then generated polyclonal antibodies against target species by immunizing rabbits with heat-inactivated bacteria. Two polyclonal antibodies were directed againstF. prausnitziitype strains that belong to different phylogroups, whereas one was directed againstC. minutastrain DSM 22607. The specificity of the antibodies was demonstrated by sorting and sequencing the stained bacterial fractions from fecal material. In addition, staining solutions including LIVE/DEAD™ BacLight™ Bacterial Viability staining and polyclonal antibodies did not severely impact bacterial viability while allowing discrimination between groups of strains. Finally, we combined these staining strategies as well as additional criteria based on bacterial shape forC. minutaand were able to detect, isolate, and cultivate newF. prausnitziiandC. minutastrains from healthy volunteer’s fecal samples.ConclusionsTargeted cell-sorting under anaerobic conditions is a promising tool for the study of fecal microbiota. It gives the opportunity to quickly analyze microbial populations, and can be used to sort EOS and/or under-represented strains of interest using specific antibodies, thus opening new avenues for culture experiments.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Medical mycology · 2026 · Journal Article
Morio F, Alanio A, Boukris-Sitbon K, Garcia-Hermoso D, et al.
Physiological reports · 2025 · Journal Article
Bérubé B, Boidin M, Gayda M, Vincent T, et al.
The Journal of emergency medicine · 2024 · Journal Article
Vincent T, Lefebvre T, Martinez M, Debaty G, et al.
Cell stem cell · 2024 · Journal Article
Vishy CE, Thomas C, Vincent T, Crawford DK, et al.
ClinicoEconomics and outcomes research : CEOR · 2023 · Journal Article
Jackson Ii LR, Friedman DJ, Francis DM, Maccioni S, et al.
Infection and immunity · 2022 · Journal Article
Bertrand BP, Heim CE, West SC, Chaudhari SS, et al.
Journal of radiosurgery and SBRT · 2022 · Journal Article
Ibet Marie YS, Erickson FT, Maurice VB, Jonna Mae DM, et al.
Human brain mapping · 2021 · Journal Article
Mohammadi H, Vincent T, Peng K, Nigam A, et al.
Medicine · 2021 · Journal Article
Allou N, Larsen K, Dubernet A, Traversier N, et al.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026 · Journal Article
Dupuy EG, Blanchette CA, Besnier F, Gagnon C, et al.
Trials · 2025 · Journal Article
Blanchette CA, Besnier F, Dupuy EG, Gagnon C, et al.
GeroScience · 2025 · Journal Article
Besnier F, Dupuy EG, Gagnon C, Vincent T, et al.
Microorganisms · 2024 · Journal Article
Binda S, Tremblay A, Iqbal UH, Kassem O, et al.
Drug metabolism and disposition: the biological fate of chemicals · 2024 · Journal Article
Jimonet P, Druart C, Blanquet-Diot S, Boucinha L, et al.
Frontiers in microbiology · 2023 · Published Erratum
Asare PT, Lee CH, Hürlimann V, Teo Y, et al.
Frontiers in aging neuroscience · 2025 · Journal Article
Bherer L, Vrinceanu T, Dupuy EG, Gayda M, et al.
Brain sciences · 2021 · Journal Article
Mohammadi H, Gagnon C, Vincent T, Kassab A, et al.
Journal of clinical medicine · 2021 · Journal Article
Talamonti D, Vincent T, Fraser S, Nigam A, et al.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026 · Journal Article
Dupuy EG, Blanchette CA, Besnier F, Gagnon C, et al.
Trials · 2021 · Clinical Trial Protocol
Dupuy EG, Besnier F, Gagnon C, Vincent T, et al.
American journal of physical medicine & rehabilitation · 2025 · Journal Article
Besnier F, Malo J, Mohammadi H, Clavet S, et al.
Heart rhythm O2 · 2023 · Journal Article
Jackson LR 2nd, Friedman DJ, Francis DM, Maccioni S, et al.
Applied and environmental microbiology · 2026 · Journal Article
Alaban LR, Bunescu A, Abi-Ghanem J, Bequet F, et al.
Microbiology resource announcements · 2022 · Journal Article
Meslier V, Plaza Oñate F, Ania M, Nehlich M, et al.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026 · Journal Article
Dupuy EG, Blanchette CA, Besnier F, Gagnon C, et al.
Neuroscience and biobehavioral reviews · 2021 · Journal Article
Intzandt B, Vrinceanu T, Huck J, Vincent T, et al.
SAGE open medical case reports · 2026 · Case Reports
Rajesh RY, Biju Seena P, Nakhutsrishvili E, Akkineni T, et al.
SAGE open medical case reports · 2026 · Case Reports
Rajesh RY, Biju Seena P, Nakhutsrishvili E, Akkineni T, et al.
Journal of global antimicrobial resistance · 2020 · Journal Article
Dubernet A, Larsen K, Masse L, Allyn J, et al.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026 · Journal Article
Dupuy EG, Blanchette CA, Besnier F, Gagnon C, et al.
Journal of biomolecular structure & dynamics · 2023 · Journal Article
Calvin DJD, Steve RJ, Kannangai R, Abraham P, et al.
Heart rhythm O2 · 2023 · Journal Article
Jackson LR 2nd, Friedman DJ, Francis DM, Maccioni S, et al.
Neuroscience and biobehavioral reviews · 2021 · Journal Article
Intzandt B, Vrinceanu T, Huck J, Vincent T, et al.
International journal of environmental research and public health · 2022 · Journal Article
Besnier F, Bérubé B, Malo J, Gagnon C, et al.
silx-kit/freesas: FreeSAS v2026.2
What's Changed 2024.09 by @kif in https://github.com/silx-kit/freesas/pull/94 Fix a few tests by @rolandmas in https://github.com/silx-kit/freesas/pull/96 Export hdf5 to zip by @kif in https://github.com/silx-kit/fr
Additional file 5 of Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions
Additional file 4. Preliminary FCM controls. (A) events gated as bacteria, (B) auto-fluorescence of fecal material in the Violet 450/50 nm and Red 670/30 nm channels, (C) potential staining with polyclonal antibodies col
Additional file 9 of Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions
Additional file 8. Random Amplified Polymorphism DNA profiles obtained with newly isolated C. minuta strains using primer D14307 [25].
Robust Robot Planning for Human-Robot Collaboration
In human-robot collaboration, the objectives of the human are often unknown to the robot. Moreover, even assuming a known objective, the human behavior is also uncertain. In order to plan a robust robot behavior, a key p
silx-kit/h5web: H5Web 17
Full Changelog: https://github.com/silx-kit/h5web/compare/v16.0.1...v17.0.0 :warning: {Breaking} All three packages are now ESM-only. We no longer provide CommonJS bundles. This shouldn't be an issue if you're using a
xraypy/xraylarch: 0.9.75
General using miniforge3 and mamba as "normal" installer. bash installer properly installs "xraylarch[larix]". 1D XRD viewer can use, set, unset mask when reading XRD TIFF images. cleanup "plugins", "modules", oth
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
American journal of physical medicine & rehabilitation · 2025 · Journal Article
Besnier F, Malo J, Mohammadi H, Clavet S, et al.
Experimental gerontology · 2024 · Journal Article
Dupuy EG, Besnier F, Gagnon C, Vincent T, et al.
Frontiers in cardiovascular medicine · 2021 · Journal Article
Besnier F, Dupuy EG, Gagnon C, Vincent T, et al.
Trials · 2021 · Clinical Trial Protocol
Dupuy EG, Besnier F, Gagnon C, Vincent T, et al.
Frontiers in microbiology · 2023 · Journal Article
Asare PT, Lee CH, Hürlimann V, Teo Y, et al.
Microbiome · 2022 · Journal Article
Bellais S, Nehlich M, Ania M, Duquenoy A, et al.
FEMS microbiology reviews · 2021 · Journal Article
d'Enfert C, Kaune AK, Alaban LR, Chakraborty S, et al.